MedPath

Study of BTX 1503 Solution in Patients with Acne Vulgaris

Phase 1
Completed
Conditions
Acne
Registration Number
ACTRN12617001127392
Lead Sponsor
Botanix Pharmaceuticals Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath